Oncogen Pharma (Malaysia) Sdn Bhd Press Releases

• Published on January 28, 2022 - 07:33 GMT

  Oncogen Pharma (Malaysia) Sdn. Bhd. Received the First ANDA Approval for Abiraterone 250mg and 500mg Tablets

  The product will be marketed by the group’s front end, Novugen Pharma (USA) LLC, which is based in Princeton, New Jersey. SHAH ALAM, SELANGOR, MALAYSIA, January 28, 2022 /⁨EINPresswire.com⁩/ -- Oncogen Pharma (Malaysia) Sdn. Bhd., the sister concern of …

  Distribution channels: Healthcare & Pharmaceuticals Industry ...
• Published on June 14, 2021 - 10:41 GMT

  ONCOGEN PHARMA MALAYSIA & BRIGHTGENE BIO-MEDICAL TECHNOLOGY ANNOUNCE STRATEGIC PARTNERSHIP TO ENTER U.S.A PHARMA MARKET

  Oncogen Pharma & BrightGene Bio-Medical Technology announced agreement signing to develop, manufacture, market, & distribute Generic products for U.S.A market. SHAH ALAM, SELANGOR, MALAYSIA, June 14, 2021 /⁨EINPresswire.com⁩/ -- Oncogen Pharma ( …

  Distribution channels: Healthcare & Pharmaceuticals Industry ...